Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$459 Mln
Revenue (TTM)
$15 Mln
Net Profit (TTM)
$0 Mln
ROE
-0.6 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
5.4
Industry P/E
--
EV/EBITDA
-3.6
Div. Yield
0 %
Debt to Equity
0
Book Value
$1.2
EPS
$-0.7
Face value
--
Shares outstanding
71,564,217
CFO
$-294.38 Mln
EBITDA
$-297.10 Mln
Net Profit
$-298.92 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shattuck Labs Inc (STTK)
| 75.9 | 63.8 | 75.9 | 659.0 | 29.7 | -26.3 | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Shattuck Labs Inc (STTK)
| 201.7 | -82.8 | 210.0 | -73.0 | -83.8 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shattuck Labs Inc (STTK)
|
6.4 | 459.4 | 1.0 | -48.8 | -324.0 | -60.3 | -- | 5.4 |
| 61.0 | 8,546.2 | 1,091.0 | 202.3 | 31.6 | 31.3 | 38.1 | 15.0 | |
| 66.7 | 8,218.7 | 88.0 | -785.0 | -808.1 | 197.5 | -- | 60.5 | |
| 43.9 | 11,764.8 | 2,320.1 | 782.6 | 39.0 | 35.5 | 15.8 | 5.3 | |
| 93.8 | 12,307.7 | 982.0 | -416.3 | -42.1 | 348.4 | -- | 60.9 | |
| 64.5 | 7,640.4 | 1,396.6 | 316.9 | 59.8 | 153.6 | 25.2 | 156.5 | |
| 546.9 | 12,545.6 | 958.4 | -288.3 | -27.8 | -42.5 | -- | 20.8 | |
| 498.3 | 14,143.5 | 2,530.2 | 451.1 | 21.3 | 70.2 | 32.7 | 30.2 | |
| 105.4 | 8,288.6 | 0.0 | -425.4 | -- | -36.7 | -- | 6.7 | |
| 310.4 | 8,644.3 | 0.0 | -303.3 | -- | -45.8 | -- | 10.1 |
Shattuck Labs, Inc., a clinical-stage biotechnology company, engages in the development of antibodies for the treatment of inflammatory and immune-mediated diseases in the United States. The company develops SL-325, a death receptor 3 blocking... monoclonal antibody, which is in Phase I clinical trial for the treatment of tumor necrosis factor like ligand 1A; and SL-425, a half-life extended version of SL-325, which is under IND-enabling chronic good laboratory practices toxicity study. It is also involved in the development of various preclinical DR3-based bispecific antibodies for the treatment of patients with inflammatory bowel disease or other immune-mediated indications; and TRIM7, an oncology-focused program. The company was incorporated in 2016 and is headquartered in Austin, Texas. Read more
Co-Founder, CEO & Director
Dr. Taylor H. Schreiber M.D., Ph.D.
Co-Founder, CEO & Director
Dr. Taylor H. Schreiber M.D., Ph.D.
Headquarters
Austin, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Shattuck Labs Inc (STTK) is $6.42 (NASDAQ) as of 02-Apr-2026 17:20 EDT. Shattuck Labs Inc (STTK) has given a return of 29.74% in the last 3 years.
Since, TTM earnings of Shattuck Labs Inc (STTK) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-5.23
|
3.10
|
|
2024
|
-0.82
|
0.77
|
|
2023
|
-3.51
|
2.12
|
|
2022
|
-0.96
|
0.55
|
|
2021
|
-7.95
|
1.32
|
The 52-week high and low of Shattuck Labs Inc (STTK) are Rs 6.81 and Rs 0.69 as of 05-Apr-2026.
Shattuck Labs Inc (STTK) has a market capitalisation of $ 459 Mln as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Shattuck Labs Inc (STTK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.17
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.